EPHX2 and breast cancer: Although sEH is found to be downregulated in malignant breast tissues and its upregulation inhibits the proliferation of BC, due to the high heterogeneity of BC cells and the complexity of BC pathogenesis, the effect of sEH is not isolated, one-sided, or guarded.